Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001771961-25-000009

Chief Accounting Officer sold 1,900 shares at $26.00 ($49,400)

  • Chief Accounting Officer acquired 1,900 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Azoy Alexander · Chief Accounting Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-26 Exercise or conversion : show line 1 in the form 10b5-1 +1,900 $13.33 $25,327 29,263 D
2025-11-26 Sale : show line 2 in the form 10b5-1 −1,900 $26.00 $49,400 27,363 D
Open-market sales · 1,900 sh · avg $26.00 · $49,400

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-11-26 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −1,900 9,500 D
Loading xslF345X05/wk-form4_1764630580.xml…